Innoviva, Inc. (INVA)
23.39
-0.25
(-1.06%)
USD |
NASDAQ |
Feb 20, 16:00
23.38
0.00 (0.00%)
After-Hours: 20:00
Innoviva Price : 23.39 for Feb. 20, 2026
Price Chart
Sep '18
Jan '19
May '19
285.00
270.00
255.00
240.00
Historical Data
Price Definition
The price of a security measures the cost to purchase 1 share of a security. For a company, price can be multiplied by shares outstanding to find the market capitalization (value of the company).
Price Range, Past 5 Years
--
Minimum
--
Maximum
--
Average
--
Median
Price Benchmarks
| Merck & Co., Inc. | 122.26 |
| Nektar Therapeutics | 73.73 |
| Regeneron Pharmaceuticals, Inc. | 779.67 |
| Oramed Pharmaceuticals, Inc. | 3.22 |
| Theravance Biopharma, Inc. | 19.66 |
Price Related Metrics
| PE Ratio | 16.78 |
| PS Ratio | 4.598 |
| PEG Ratio | 0.1635 |
| Price to Book Value | 1.732 |
| Price to Free Cash Flow | 9.412 |
| Earnings Yield | 5.96% |
| Market Cap | 1.749B |
| PEGY Ratio | 0.1635 |
| Operating PE Ratio | 11.02 |
| Normalized PE Ratio | 13.58 |